These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3158552)

  • 1. Spironolactone in combination drug therapy for unresponsive hirsutism.
    Pittaway DE; Maxson WS; Wentz AC
    Fertil Steril; 1985 Jun; 43(6):878-82. PubMed ID: 3158552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of clinical response in hirsute women treated with spironolactone.
    Crosby PD; Rittmaster RS
    Fertil Steril; 1991 Jun; 55(6):1076-81. PubMed ID: 1828043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spironolactone in the treatment of hirsutism.
    Anttila L; Ruutiainen K; Erkkola R
    Ann Chir Gynaecol Suppl; 1987; 202():32-4. PubMed ID: 3310825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.
    Diri H; Karaburgu S; Acmaz B; Unluhizarci K; Tanriverdi F; Karaca Z; Kelestimur F
    Gynecol Endocrinol; 2016; 32(1):42-5. PubMed ID: 26370923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of spironolactone on testosterone fractions and sex-hormone binding globulin binding capacity in hirsute women.
    Marcondes JA; Minanni SL; Luthold WW; Lerário AC; Nery M; Mendonça BB; Wajchenberg BL; Kirschner MA
    J Endocrinol Invest; 1995 Jun; 18(6):431-5. PubMed ID: 7594237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hirsutism in women with flutamide.
    Marcondes JA; Minnani SL; Luthold WW; Wajchenberg BL; Samojlik E; Kirschner MA
    Fertil Steril; 1992 Mar; 57(3):543-7. PubMed ID: 1531466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of sex hormone binding globulin and free androgen index in the estimation of androgenic cases].
    Qiao FY; Lauritzen C
    J Tongji Med Univ; 1990; 10(2):124-8. PubMed ID: 2145442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High serum prostate-specific antigen concentrations in hirsute women do not decrease with treatment by the combination of spironolactone and the contraceptive pill.
    Guzelmeric K; Seker N; Unal O; Turan C
    Gynecol Endocrinol; 2004 Oct; 19(4):190-5. PubMed ID: 15724801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism.
    Keleştimur F; Everest H; Unlühizarci K; Bayram F; Sahin Y
    Eur J Endocrinol; 2004 Mar; 150(3):351-4. PubMed ID: 15012621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome.
    Ezeh U; Huang A; Landay M; Azziz R
    J Womens Health (Larchmt); 2018 Jul; 27(7):892-902. PubMed ID: 29878857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of spironolactone in treatment of hirsutism.
    Cumming DC
    Cleve Clin J Med; 1990 May; 57(3):285-7. PubMed ID: 2357784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
    O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
    J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocrine effects of spironolactone used as an antiandrogen.
    Young RL; Goldzieher JW; Elkind-Hirsch K
    Fertil Steril; 1987 Aug; 48(2):223-8. PubMed ID: 2956130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term treatment of hirsutism related to micropolycystic ovary syndrome with a combination type oral contraceptive containing desogestrel.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1989; 20(1):35-7. PubMed ID: 2528880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hirsutism with spironolactone.
    Tremblay RR
    Clin Endocrinol Metab; 1986 May; 15(2):363-71. PubMed ID: 2941190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
    Maier PS; Mattiello SS; Lages L; Spritzer PM
    Gynecol Endocrinol; 2012 Aug; 28(8):606-10. PubMed ID: 22329763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.